Navigation Links
Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
Date:4/17/2008

BAXTER INTERNATIONAL INC.

Note to Consolidated Statement of Income

Three Months Ended March 31, 2008

Description of Adjustment and Reconciliation of GAAP to Non-GAAP Measures

(unaudited)

(in millions, except per share and percentage data)

The company's GAAP results for the three months ended March 31, 2008

included a charge related to COLLEAGUE infusion pumps, which impacted the

results as follows:

Income

Pre-tax Tax Net Diluted

Income Expense Income EPS

------------------------------------

GAAP $534 $105 $429 $0.67

COLLEAGUE infusion pump charge (A) 53 8 45 0.07

------------------------------------

Excluding specified item $587 $113 $474 $0.74

====================================

Effective tax rate 19.3%

(A) Included in the Cost of Goods Sold line in the accompanying

consolidated statement of income. Excluding this charge, adjusted

gross profit was $1,433 and the adjusted gross profit percentage was

49.8%.

BAXTER INTERNATIONAL INC.

Condensed Consolidated Balance Sheets

(unaudited)

($ in millions)

March 31, 2008 December 31, 2007

-------------- -----------------

Assets

------

Cash and equivalents
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
3. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
4. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
7. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
8. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
9. Baxter International Fourth Quarter 2007 Financial Results Conference Call
10. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... have developed a simple, cheap, accurate test to find ... have created a custom-made bacteria that glows green when ... explosives. , The bacteria can be mixed into a ... forms green patches to indicate the presence of landmines. ... cheap to produce, could be delivered from the air ...
(Date:12/16/2009)... Dec. 16 Martek Biosciences Corporation (Nasdaq: ... fourth quarter and fiscal year ended October 31, 2009. ... 3% from $90.4 million in the fourth quarter of ... per diluted share, for the fourth quarter of fiscal ... $0.31 per diluted share, in last year,s fourth quarter. ...
(Date:12/16/2009)... -- Capitalizing on the continued strong growth ... venture capital market, leaders from BioCrossroads, Eli Lilly ... University, Purdue University, the University of Notre Dame, ... announced the establishment of the INext Fund, a ... Organized through BioCrossroads, Indiana,s initiative to grow, expand ...
(Date:12/16/2009)... ultimate CHO cell culture supplement? InVitria has what scientists have ... media supplement that improves the growth and productivity of CHO ... Zap-CHO is an animal free, well defined and consistent recombinant ... ... CO (PRWEB) December 16, 2009 -- Scientists working with CHO ...
Breaking Biology Technology:Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2
... GE Healthcare announced today that Rockwood ... facilities in the Spokane, Washington area, has purchased a ... of the new technologies the clinic is installing is ... appointments, update their patient profile and make co-payments electronically. ...
... (Commerce) has qualified five small businesses for investor tax ... Tax Credit Programs. , ,"By encouraging investors through tax ... to turn these great ideas into viable, job-creating businesses," ... and Venture Fund Tax Credit Programs offer Wisconsin income ...
... National Committee for Quality Assurance (NCQA) has ... as the first electronic health record (EHR) software shown ... American Diabetes Association Diabetes Physician Recognition Program (DPRP). ... required to pull a random sample of their patient ...
Other Biology Technology:Five technology companies qualify for investor tax credits 2
(Date:12/15/2009)... brain diseases such as Alzheimer,s and Parkinson,s, doctors can ... help a patient. , But they come up empty-handed ... patients with ataxia disabling disorders that rob people ... neurologists are trying to change that with the help ... Institute of Neurological Disorders and Stroke to establish a ...
(Date:12/15/2009)... Clinical Laboratory, San Diego, California, has been awarded ... (CAP), based on results of a recent onsite ... advised of this national recognition and congratulated for ... Biotech Inc. GenWay Clinical Laboratory is one of ... Laboratory Accreditation Program, begun in the early 1960s, ...
(Date:12/15/2009)... available in German ., Despite the ... the globe, cultures vary as to how space is ... use egocentric terms such as ,left, right, front, back, ... like ,north, south, east, west, at all times for ... or "There is an snake by your Northern leg". ...
Breaking Biology News(10 mins):UF to lead national effort to help patients with rare brain disease 2UF to lead national effort to help patients with rare brain disease 3More than a jump to the left 2Are Microbes Headed Back to School this Fall 3F 53556 1Are Microbes Headed Back to School this Fall 3F 53556 2Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 1Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 2Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 3Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 4Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 5Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 6Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 7Amgen Announces Positive Top Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa 2 4817 8Surgical Masks Help Ward Off Flu Maybe 53553 1Surgical Masks Help Ward Off Flu Maybe 53553 2Surgical Masks Help Ward Off Flu Maybe 53553 3Surgical Masks Help Ward Off Flu Maybe 53553 4
... growing faster than anywhere else in the world. This is ... urban environment and effect of cities on rural areas. One ... being over-looked. , Joy Clancy from the University of Twente ... African Journal of Ecology . She says "A hundred ...
... climate change, pollution and human activity. ESA,s ERS and ... region for the last 17 years. These long term ... be key in implementing the newly adopted European Commission ... , The policy highlights new opportunities in the region ...
... fish are prompting widespread consumption advisories and uncertainty among ... researchers at North Carolina State University have developed a ... country predict which areas are likely to have fish ... help officials address public uncertainty by developing health advisories ...
Other Biology News:ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2
...
...
... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related ... continual availability of new radiolabeled ligands selected ... offers a wide range of products and ... including over 400 state-of-the-art radioligands. If you ...
... was developed using a protein engineering approach that ... pocket of wild-type DNase I. These changes markedly ... The result is a versatile enzyme that has ... ability to maintain at least 50% of peak ...
Biology Products: